Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection

Affiliations

• ¹ Institute of Microbiology of the Chinese Academy of Sciences, Beijing 100101, China; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
• ² Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
• ³ School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
• ⁴ Clinical Trial Research Center, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
• ⁵ Yunnan University, Kunming, China.
• ⁶ Anhui Zhifei Longcom Biopharmaceutical, Hefei, China.
• ⁷ Institute of Microbiology of the Chinese Academy of Sciences, Beijing 100101, China.
• ⁸ Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China.
• ⁹ Institute of Microbiology of the Chinese Academy of Sciences, Beijing 100101, China; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China. Electronic address: gaof@im.ac.cn.